HSBC Holdings’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.59M Buy
196,250
+157,863
+411% +$3.44M ﹤0.01% 1179
2026
Q1
$644K Buy
38,387
+21,764
+131% +$412K ﹤0.01% 2094
2025
Q4
$314K Buy
+16,623
New +$278K ﹤0.01% 2512
2025
Q2
Sell
-17,029
Closed -$299K 3052
2025
Q1
$299K Sell
17,029
-102
-0.6% -$2.2K ﹤0.01% 2377
2024
Q4
$365K Buy
17,131
+1,109
+7% +$27K ﹤0.01% 2375
2024
Q3
$501K Buy
16,022
+1,380
+9% +$34.3K ﹤0.01% 2004
2024
Q2
$222K Sell
14,642
-573
-4% -$6.93K ﹤0.01% 2487
2024
Q1
$161K Sell
15,215
-267
-2% -$2.67K ﹤0.01% 2742
2023
Q4
$189K Buy
15,482
+3,762
+32% +$30.8K ﹤0.01% 2488
2023
Q3
$80.9K Buy
+11,720
New +$108K ﹤0.01% 2580
2022
Q1
Sell
-5,353
Closed -$246K 3280
2021
Q4
$246K Buy
+5,353
New +$279K ﹤0.01% 2918
2021
Q3
Sell
-4,369
Closed -$398K 3000
2021
Q2
$398K Buy
+4,369
New +$347K ﹤0.01% 2331
2021
Q1
Sell
-5,240
Closed -$383K 2771
2020
Q4
$383K Buy
+5,240
New +$304K ﹤0.01% 2385

Other funds holding CDNA

HSBC Holdings's CDNA Position: Q2 2026 in Review

HSBC Holdings increased its CareDx (CDNA) stake by 411% in Q2 2026, buying an estimated $3.44M and bringing the position to 196,250 shares worth $5.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1179.

HSBC Holdings first reported a position in CDNA in Q4 2020 and has held it in 13 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • HSBC Holdings held 196,250 shares of CareDx worth $5.59M as of Q2 2026.
  • HSBC Holdings bought 157,863 CareDx shares in Q2 2026, an estimated $3.44M.
  • CareDx made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1179 holding.
  • HSBC Holdings first reported a position in CareDx in Q4 2020 and has held it in 13 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.